Your browser doesn't support javascript.
loading
Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial.
Pepin, Stephanie; Nicolas, Jean-François; Szymanski, Henryk; Leroux-Roels, Isabel; Schaum, Thomas; Bonten, Marc; Icardi, Giancarlo; Shrestha, Anju; Tabar, Cynthia.
Affiliation
  • Pepin S; Global Clinical Sciences, Sanofi Pasteur, Marcy L'Etoile, France.
  • Nicolas JF; Clinical Immunology & Allergology Department, Centre Hospitalier Lyon-Sud, Lyon, France.
  • Szymanski H; Paediatrics, St Hedwig of Silesia Hospital Trzebnica, Prusicka, Trzebnica, Poland.
  • Leroux-Roels I; Centrum Voor Vaccinologie, Ghent University Hospital, Ghent, Belgium.
  • Schaum T; RED-Institut, Oldenburg in Holstein, Germany.
  • Bonten M; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Icardi G; Department of Health Sciences, Ospedale Policlinico S. Martino IRCCS, University of Genoa, Genoa, Italy.
  • Shrestha A; Global Pharmacovigilance, Sanofi Pasteur, Swiftwater, PA, USA.
  • Tabar C; Global Clinical Sciences, Sanofi Pasteur, Marcy L'Etoile, France.
Hum Vaccin Immunother ; 17(12): 5475-5486, 2021 12 02.
Article in En | MEDLINE | ID: mdl-34714720

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Hum Vaccin Immunother Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Hum Vaccin Immunother Year: 2021 Document type: Article Affiliation country: Country of publication: